Aaron Morris

Aaron Morris is the co-founder and CEO of PostEra, an AI-powered biotechnology company based in Boston, Massachusetts. Under his leadership, the enterprise raised a $24 million Series A funding round in 2022 and established strategic research partnerships with major pharmaceutical firms, including Amgen and Pfizer. Morris also helped launch the COVID Moonshot, a global open-science consortium that secured a $68 million grant from the National Institutes of Health to develop patent-free antiviral therapeutics. Prior to his executive career, he built a foundation in applied mathematics and computer science by earning a degree from the University of Oxford. PostEra's computational chemistry platform has successfully screened over 100 million compounds to accelerate small molecule drug discovery. His current focus centers on deploying machine learning models to significantly reduce the time and capital required for preclinical pharmaceutical development.